Actas Urol Esp (Engl Ed)

1. AYDIN U, Cetin S, Koparal MY, Coskun C, et al
   Is the presence of lymphovascular invasion associated with recurrence and progression in bladder cancer patients that have received adequate BCG therapy?
   Actas Urol Esp (Engl Ed). 2025 Apr 18:501785. doi: 10.1016/j.acuroe.2025.501785.
   

   >> Share

   
   
2. SUBIELA JD, Guerrero-Ramos F, Rodriguez-Faba O, Aumatell J, et al
   New insights and emerging approaches in bladder-sparing treatment for muscle-invasive bladder cancer.
   Actas Urol Esp (Engl Ed). 2025 Apr 19:501758. doi: 10.1016/j.acuroe.2025.501758.
   

   >> Share

   
   

   
   Am J Clin Oncol

3. AMAN H, Hamza M, Ramzan A, Saqib M, et al
   Standard Versus Extended Pelvic Lymphadenectomy in Patients With Bladder Cancer: A Systematic Review and Meta-analysis.
   Am J Clin Oncol. 2025 Apr 21. doi: 10.1097/COC.0000000000001206.
   

   >> Share

   
   

   
   Am J Clin Pathol

4. SANGOI AR, Shahabi A, Hirsch MS, Kao CS, et al
   Urothelial carcinoma in situ with "early papillary formation" vs "lateral spread/shoulder lesion" of prior high-grade noninvasive papillary urothelial carcinoma: A survey of pathologist and urologist interpretations.
   Am J Clin Pathol. 2025;163:629-640.
   

   >> Share

   
   
5. CASE KB, Martini DJ, Dababneh MN, Bidot S, et al
   Trop-2 and Ephrin B2 expression in urothelial carcinoma with divergent differentiation and aggressive urothelial carcinoma subtypes.
   Am J Clin Pathol. 2025;163:618-628.
   

   >> Share

   
   

   
   Ann Surg Oncol

6. YE Z, Li Y, Sun Y, He C, et al
   Leveraging Deep Learning in Real-Time Intelligent Bladder Tumor Detection During Cystoscopy: A Diagnostic Study.
   Ann Surg Oncol. 2025;32:3220-3226.
   

   >> Share

   
   

   
   Asian J Endosc Surg

7. BABA T, Hamada S, Sakiyama H, Kiyuna S, et al
   Simultaneous Laparoscopic and Thoracoscopic Biopsy via a Single Skin Incision Using a Port-Sharing Procedure in Infantile Neuroblastoma: A Case Report.
   Asian J Endosc Surg. 2025;18:e70064.
   

   >> Share

   
   

   
   Biochim Biophys Acta Rev Cancer

8. FREITAS R, Peixoto A, Santos LL, Ferreira JA, et al
   Glycan-based therapeutic approaches for bladder cancer: Overcoming clinical barriers.
   Biochim Biophys Acta Rev Cancer. 2025 Apr 22:189327.
   

   >> Share

   
   
9. SABEEL Z, Wang J, Dong J, Liu Y, et al
   The duality of GSK-3beta in urinary bladder cancer: Tumor suppressor and promoter roles through multiple signaling pathways.
   Biochim Biophys Acta Rev Cancer. 2025;1880:189324.
   

   >> Share

   
   

   
   Biol Direct

10. DAI H, Yu Z, Zhao Y, Jiang K, et al
    Integrating machine learning models with multi-omics analysis to decipher the prognostic significance of mitotic catastrophe heterogeneity in bladder cancer.
    Biol Direct. 2025;20:56.
    

    >> Share

    
    

    
    Biomol Biomed

11. YIN ZX, Qiu Y, Xu C, Pei C, et al
    Comprehensive analysis of angiogenesis and stemness-related genes in chemotherapy and immunotherapy of bladder cancer.
    Biomol Biomed. 2025 Apr 18. doi: 10.17305/bb.2025.12046.
    

    >> Share

    
    

    
    BJC Rep

12. TSUKAHARA S, Shiota M, Matsumoto T, Takamatsu D, et al
    Monitoring circulating tumor DNA by recurrent hotspot mutations in bladder cancer.
    BJC Rep. 2025;3:26.
    

    >> Share

    
    

    
    BMC Med Genomics

13. LV Z, Zhao S, Wu H
    LIMA1 inhibits cisplatin resistance and malignant biological behavior of bladder cancer cells by suppressing the Wnt/beta-catenin pathway.
    BMC Med Genomics. 2025;18:78.
    

    >> Share

    
    

    
    BMC Urol

14. DENG D, Li J, Luo J, Liang H, et al
    Transurethral resection of a giant bladder leiomyoma.
    BMC Urol. 2025;25:97.
    

    >> Share

    
    

    
    Cancer Med

15. ANNAKIB S, Di Meglio E, Dibert-Bekoy Y, Chevallier T, et al
    Patient Versus Clinician Reported Symptoms Agreement in Advanced Metastatic Bladder Cancer Patients.
    Cancer Med. 2025;14:e70896.
    

    >> Share

    
    

    
    Cell Death Differ

16. CHEN K, Chen J, Cong Y, He Q, et al
    TTK promotes mitophagy by regulating ULK1 phosphorylation and pre-mRNA splicing to inhibit mitochondrial apoptosis in bladder cancer.
    Cell Death Differ. 2025 Apr 23. doi: 10.1038/s41418-025-01492.
    

    >> Share

    
    

    
    Cell Rep

17. WANG JM, Zhang FH, Xie HY, Liu ZX, et al
    KIF26B promotes bladder cancer progression via activating Wnt/beta-catenin signaling in a TRAF2-dependent pathway.
    Cell Rep. 2025;44:115595.
    

    >> Share

    
    

    
    Clin Nucl Med

18. MAN X, Dong C, Song X, Dong A, et al
    Intense FDG Activity of Renal Granuloma Following Intravesical Bacillus Calmette-Guerin Therapy for Bladder Cancer Mimicking Malignancy.
    Clin Nucl Med. 2025 Apr 23. doi: 10.1097/RLU.0000000000005810.
    

    >> Share

    
    

    
    Discov Oncol

19. MOREIRA IB, Buettner FFR
    Glycosphingolipids as emerging attack points in bladder cancer.
    Discov Oncol. 2025;16:569.
    

    >> Share

    
    
20. JIN J, Wang W, Zhao K, Xu G, et al
    The genetic associations of lipidome on bladder cancer: a Mendelian randomization study.
    Discov Oncol. 2025;16:586.
    

    >> Share

    
    
21. JING X, Deng Y
    ADCYAP1 as a pan-solid cancer biomarker: predictor of immunotherapy efficacy in bladder cancer and prognostic potential across solid tumors.
    Discov Oncol. 2025;16:593.
    

    >> Share

    
    

    
    Eur J Cancer

22. DUWE G, Mercier D, Kauth V, Moench K, et al
    Development of an artificial intelligence-generated, explainable treatment recommendation system for urothelial carcinoma and renal cell carcinoma to support multidisciplinary cancer conferences.
    Eur J Cancer. 2025;220:115367.
    

    >> Share

    
    

    
    Eur J Nucl Med Mol Imaging

23. NG TSC, Liu M, Robertson M, Konik A, et al
    A pilot study of [(18)F]F-fluciclovine positron emission tomography/computed tomography for staging muscle invasive bladder cancer preceding radical cystectomy.
    Eur J Nucl Med Mol Imaging. 2025 Apr 21. doi: 10.1007/s00259-025-07287.
    

    >> Share

    
    

    
    Eur Urol

24. GUPTA S, Hensley PJ, Li R, Choudhury A, et al
    Bladder Preservation Strategies in Muscle-invasive Bladder Cancer: Recommendations from the International Bladder Cancer Group.
    Eur Urol. 2025 Apr 22:S0302-2838(25)00189-7. doi: 10.1016/j.eururo.2025.
    

    >> Share

    
    
25. GHODOUSSIPOUR S, Bivalacqua T, Bryan RT, Li R, et al
    A Systematic Review of Novel Intravesical Approaches for the Treatment of Patients with Non-muscle-invasive Bladder Cancer.
    Eur Urol. 2025 Apr 18:S0302-2838(25)00123-X. doi: 10.1016/j.eururo.2025.
    

    >> Share

    
    

    
    Fr J Urol

26. ADYPAGAVANE A, Lebacle C, Peyrottes A, Irani J, et al
    BCG MEDAC(R) for the treatment of non-muscle invasive bladder tumors: Adverse events and predictive factors for tolerance.
    Fr J Urol. 2025;35:102843.
    

    >> Share

    
    

    
    Front Oncol

27. KATTAN J, Kattan C, Aoun F, Nemr E, et al
    The practical roadmap for peri-cystectomy approaches in muscle-invasive bladder cancer.
    Front Oncol. 2025;15:1543837.
    

    >> Share

    
    

    
    Inflamm Res

28. ZAFFRAN I, Zoabi Y, Gaur P, Alekberli FR, et al
    Eosinophils but not mast cells exert anti-tumorigenic activity, without being predictive markers of the long-term response to Bacillus Calmette-Guerin (BCG) therapy in patients with bladder carcinoma.
    Inflamm Res. 2025;74:68.
    

    >> Share

    
    

    
    Int J Urol

29. AKPINAR C, Suer E, Akdogan B, Izol V, et al
    The effect of neoadjuvant chemotherapy on survival outcomes in patients with variant histologies who underwent radical cystectomy with precystectomy diagnostic accuracy: A multicenter study of the Turkish Urooncology Association.
    Int J Urol. 2025;32:508-515.
    

    >> Share

    
    

    
    Int Urol Nephrol

30. WONG TR, Sun C, Ledesma B, Isali I, et al
    The role of angiogenin in bladder cancer: where are we in 2025?
    Int Urol Nephrol. 2025 Apr 22. doi: 10.1007/s11255-025-04517.
    

    >> Share

    
    

    
    Int Wound J

31. 
    RETRACTION: Comparative Analysis of Wound Healing Techniques in Postoperative Bladder Cancer Patients.
    Int Wound J. 2025;22:e70541.
    

    >> Share

    
    

    
    J Biomater Sci Polym Ed

32. POLATI D, Neerati P
    Synergistic effects of curcumin and piperine in cocrystal form: a breakthrough in bladder cancer therapy.
    J Biomater Sci Polym Ed. 2025 Apr 24:1-28. doi: 10.1080/09205063.2025.2491606.
    

    >> Share

    
    

    
    J Clin Oncol

33. BRYAN RT, Liu W, Pirrie SJ, Amir R, et al
    Errata: Randomized Comparison of Magnetic Resonance Imaging Versus Transurethral Resection for Staging New Bladder Cancers: Results From the Prospective BladderPath Trial.
    J Clin Oncol. 2025 Apr 23:JCO2500779. doi: 10.1200/JCO-25-00779.
    

    >> Share

    
    

    
    J Robot Surg

34. LUO J, Guo L, Fan J, Chen L, et al
    A review and meta-analysis: comparing the efficacy of robot-assisted and open radical cystectomy in elderly bladder cancer patients.
    J Robot Surg. 2025;19:168.
    

    >> Share

    
    

    
    Mol Omics

35. CHEN Y, Xie H, Zou Y, Lai X, et al
    Retraction: Tetracycline-controllable artificial microRNA-HOTAIR + EZH2 suppressed the progression of bladder cancer cells.
    Mol Omics. 2025 Apr 22. doi: 10.1039/d5mo90007.
    

    >> Share

    
    

    
    Nagoya J Med Sci

36. KAMIKAWA H, Matsukawa Y, Nishii H, Naito Y, et al
    A case of severe immune-related adverse events, myocarditis with myositis, and myasthenia gravis overlap syndrome following adjuvant nivolumab administration for muscle-invasive bladder cancer.
    Nagoya J Med Sci. 2025;87:156-162.
    

    >> Share

    
    

    
    Oncogene

37. HU H, Zhan X, Xiong Y, Yuan R, et al
    Non-classic deubiquitinase USP13 inhibits bladder cancer metastasis through destabilizing cytoplasmic KDM3A.
    Oncogene. 2025 Apr 19. doi: 10.1038/s41388-025-03410.
    

    >> Share

    
    

    
    Strahlenther Onkol

38. OZYIGIT G, Kahvecioglu A, Cengiz M, Yedekci FY, et al
    The effect of incidental dose to pelvic nodes in bladder-only irradiation in the era of IMRT: a dosimetric study.
    Strahlenther Onkol. 2025;201:501-506.
    

    >> Share

    
    

    
    Talanta

39. QIU X, Wang F, Gao X, Zhang H, et al
    Detection of hyaluronidase in urine using hyaluronic acid-coated silver nanoparticles-based surface-enhanced Raman spectroscopy for the diagnosis of bladder cancer.
    Talanta. 2025;294:128139.
    

    >> Share

    
    

    
    Urol Oncol

40. LIM BJH, Fong KY, Lu T, Ong J, et al
    BCG response and oncological outcomes in high risk nonmuscle invasive bladder cancer following previously treated upper tract urothelial carcinoma: A propensity-matched analysis.
    Urol Oncol. 2025 Apr 22:S1078-1439(25)00126.
    

    >> Share

    
    
41. ZHANG JH, Joyce DD, Shan Y, Fadel A, et al
    National complication and cost burden of transurethral resection of bladder tumor for bladder cancer.
    Urol Oncol. 2025 Apr 23:S1078-1439(25)00085.
    

    >> Share

    
    

    
    Virchows Arch

42. MUSANGILE FY, Matsuzaki I, Iwamoto R, Sagan K, et al
    Comparative analysis of non-coding and coding DNA mutations in flat urothelial lesions: biological implications and insights.
    Virchows Arch. 2025;486:729-737.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share